These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24204987)

  • 1. Congenital hypogonadotropic hypogonadism during childhood: presentation and genetic analyses in 46 boys.
    Vizeneux A; Hilfiger A; Bouligand J; Pouillot M; Brailly-Tabard S; Bashamboo A; McElreavey K; Brauner R
    PLoS One; 2013; 8(10):e77827. PubMed ID: 24204987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
    Hero M; Tommiska J; Vaaralahti K; Laitinen EM; Sipilä I; Puhakka L; Dunkel L; Raivio T
    Fertil Steril; 2012 May; 97(5):1242-7. PubMed ID: 22405597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism.
    Rohayem J; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2015 Sep; 3(5):882-7. PubMed ID: 26266675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism.
    Wang Y; Gong C; Qin M; Liu Y; Tian Y
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):757-766. PubMed ID: 28833369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
    Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
    PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma inhibin B and antimüllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay.
    Adan L; Lechevalier P; Couto-Silva AC; Boissan M; Trivin C; Brailly-Tabard S; Brauner R
    Med Sci Monit; 2010 Nov; 16(11):CR511-7. PubMed ID: 20980953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
    Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital hypogonadotropic hypogonadism and Kallmann syndrome in males].
    Ghervan C; Young J
    Presse Med; 2014 Feb; 43(2):152-61. PubMed ID: 24456696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys.
    Kohva E; Huopio H; Hietamäki J; Hero M; Miettinen PJ; Raivio T
    Hum Reprod; 2019 May; 34(5):863-871. PubMed ID: 31067328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.
    Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J
    Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
    Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Analysis of Genotypes and Phenotypes in Chinese Male Pediatric Patients With Congenital Hypogonadotropic Hypogonadism.
    Wang Y; Qin M; Fan L; Gong C
    Front Endocrinol (Lausanne); 2022; 13():846801. PubMed ID: 35669683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Layman LC
    Mol Cell Endocrinol; 2011 Oct; 346(1-2):74-83. PubMed ID: 21856375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.